![](https://aspargolabs.com/wp-content/uploads/2020/09/investor-03.jpg)
PRESS RELEASE | Dec / 2023
Aspargo Announces Completion of Dosing of All Subjects in Sildenafil Oral Suspension Bioavailability Study and Initiation of Dosing in Companion Food-Effect Study
READ MORE
To find out more about Aspargo Labs, send us a message.